An In-House RD1-Based Enzyme-Linked Immunospot-Gamma Interferon Assay Instead of the Tuberculin Skin Test for Diagnosis of Latent Mycobacterium tuberculosis Infection

ABSTRACT Identification of individuals infected with Mycobacterium tuberculosis is essential for the control of tuberculosis (TB). The specificity of the currently used tuberculin skin test (TST) is poor because of the broad antigenic cross-reactivity of purified protein derivative (PPD) with BCG vaccine strains and environmental mycobacteria. Both ESAT-6 and CFP-10, two secretory proteins that are highly specific for M. tuberculosis complex, elicit strong T-cell responses in subjects with TB. Using an enzyme-linked immunospot (ELISPOT)-IFN-γ assay and a restricted pool of peptides derived from ESAT-6 and CFP-10, we have previously demonstrated a high degree of specificity and sensitivity of the test for the diagnosis of TB. Here, 119 contacts of individuals with contagious TB who underwent TST and the ELISPOT-IFN-γ assay were consecutively recruited. We compared the efficacy of the two tests in detecting latent TB infection and defined a more appropriate TST cutoff point. There was little agreement between the tests (k = 0.33, P < 0.0001): 53% of the contacts with a positive TST were ELISPOT negative, and 7% with a negative TST were ELISPOT positive. Furthermore, respectively 76 and 59% of the ELISPOT-negative contacts responded in vitro to BCG and PPD, suggesting that most of them were BCG vaccinated or infected with nontuberculous mycobacteria. The number of spot-forming cells significantly correlated with TST induration (P < 0.0001). Our in-house ELISPOT assay based on a restricted pool of highly selected peptides is more accurate than TST for identifying individuals with latent TB infection and could improve chemoprophylaxis for the control of TB.

[1]  R. Joshi,et al.  Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. , 2005, JAMA.

[2]  Catherine D DeAngelis,et al.  Tuberculosis--a global problem requiring a global solution. , 2005, JAMA.

[3]  Ted Cohen,et al.  Incident Tuberculosis among Recent US Immigrants and Exogenous Reinfection , 2005, Emerging infectious diseases.

[4]  J. Lundgren,et al.  Prospective Evaluation of a Whole-Blood Test Using Mycobacterium tuberculosis-Specific Antigens ESAT-6 and CFP-10 for Diagnosis of Active Tuberculosis , 2005, Clinical Diagnostic Laboratory Immunology.

[5]  Ajit Lalvani,et al.  Diagnosis of tuberculosis in South African children with a T cell-based assay: a prospective cohort study , 2004, The Lancet.

[6]  M. Pai,et al.  Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review , 2004 .

[7]  Paolo Scarpellini,et al.  Selected Pool of Peptides from ESAT-6 and CFP-10 Proteins for Detection of Mycobacterium tuberculosis Infection , 2004, Journal of Clinical Microbiology.

[8]  L. Fabbri,et al.  T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure. , 2004, American journal of respiratory and critical care medicine.

[9]  R. Coker,et al.  Screening programmes for tuberculosis in new entrants across Europe. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[10]  R. Adegbola,et al.  Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  R. Coker Compulsory screening of immigrants for tuberculosis and HIV , 2004, BMJ : British Medical Journal.

[12]  S. Lewis,et al.  So inhaled steroids slow the rate of decline of FEV1 in patients with COPD after all? , 2003, Thorax.

[13]  A. Fietta,et al.  Comparison of a whole-blood interferon-gamma assay and tuberculin skin testing in patients with active tuberculosis and individuals at high or low risk of Mycobacterium tuberculosis infection. , 2003, American journal of infection control.

[14]  J. Deeks,et al.  Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak , 2003, The Lancet.

[15]  P. Hopewell,et al.  Clinical practice. Latent tuberculosis infection. , 2002, The New England journal of medicine.

[16]  H. Ayles,et al.  Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells , 2002, AIDS.

[17]  T. Eguale,et al.  Immune Responses to the Mycobacterium tuberculosis-Specific Antigen ESAT-6 Signal Subclinical Infection among Contacts of Tuberculosis Patients , 2002, Journal of Clinical Microbiology.

[18]  P. Klenerman,et al.  Direct Ex Vivo Analysis of Antigen-Specific IFN-γ-Secreting CD4 T Cells in Mycobacterium tuberculosis-Infected Individuals: Associations with Clinical Disease State and Effect of Treatment1 , 2001, The Journal of Immunology.

[19]  J. Deeks,et al.  Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells , 2001, The Lancet.

[20]  R. Wilkinson,et al.  Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. , 2001, American journal of respiratory and critical care medicine.

[21]  A. Hill,et al.  Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. , 2001, The Journal of infectious diseases.

[22]  S. Kaufmann,et al.  Increased Numbers of ESAT-6- and Purified Protein Derivative-Specific Gamma Interferon-Producing Cells in Subclinical and Active Tuberculosis Infection , 2000, Infection and Immunity.

[23]  P. Andersen,et al.  Specific immune-based diagnosis of tuberculosis , 2000, The Lancet.

[24]  T. Ottenhoff,et al.  Antigenic Equivalence of Human T-Cell Responses toMycobacterium tuberculosis-Specific RD1-Encoded Protein Antigens ESAT-6 and Culture Filtrate Protein 10 and to Mixtures of Synthetic Peptides , 2000, Infection and Immunity.

[25]  R. Belshe,et al.  Mucosal bacille calmette-Guérin vaccination of humans inhibits delayed-type hypersensitivity to purified protein derivative but induces mycobacteria-specific interferon-gamma responses. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  T. Ottenhoff,et al.  Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10. , 2000, The Journal of infectious diseases.

[27]  V. Boussiotis,et al.  IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. , 2000, The Journal of clinical investigation.

[28]  P. Andersen,et al.  Diagnosis of Tuberculosis Based on the Two Specific Antigens ESAT-6 and CFP10 , 2000, Clinical Diagnostic Laboratory Immunology.

[29]  C. Dye,et al.  Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. , 1999, JAMA.

[30]  T. Eguale,et al.  Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. , 1999, The Journal of infectious diseases.

[31]  B. Gicquel,et al.  A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). , 1998, Microbiology.

[32]  H. Dockrell,et al.  Whole blood cytokine assays--a new generation of diagnostic tests for tuberculosis? , 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[33]  L. Codecasa,et al.  Acceptance of isoniazid preventive treatment by close contacts of tuberculosis cases: a 692-subject Italian study. , 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[34]  C. F. von Reyn,et al.  In vitro cellular and cytokine responses to mycobacterial antigens: application to diagnosis of tuberculosis infection and assessment of response to mycobacterial vaccines. , 1997, The American journal of the medical sciences.

[35]  P. Andersen,et al.  Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis. , 1996, Journal of immunology.

[36]  G. Mahairas,et al.  Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis , 1996, Journal of bacteriology.

[37]  D. Vlahov,et al.  Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection. , 1995, Archives of internal medicine.

[38]  A. L. Sørensen,et al.  Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis , 1995, Infection and immunity.

[39]  W. Grove Statistical Methods for Rates and Proportions, 2nd ed , 1981 .

[40]  P. Askenase,et al.  Basophils in tuberculin and "Jones-Mote" delayed reactions of humans. , 1976, The Journal of clinical investigation.

[41]  J. Fleiss,et al.  Statistical methods for rates and proportions , 1973 .

[42]  D. T. Carr The tuberculin skin test. , 1972, The American review of respiratory disease.

[43]  P. Klenerman,et al.  Ex vivo characterization of early secretory antigenic target 6-specific T cells at sites of active disease in pleural tuberculosis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  M. Pai,et al.  Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. , 2004, The Lancet. Infectious diseases.